X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/25/2918493/0/en/Idorsia-announces-financial-results-for-the-first-half-2024.html
https://www.globenewswire.com/news-release/2024/07/18/2915501/0/en/Invitation-to-Idorsia-s-Half-Year-2024-Financial-Reporting-webcast-and-conference-call.html
https://ml-eu.globenewswire.com/Resource/Download/27025b97-6462-4b44-a696-d2c8d3672ae3
https://www.globenewswire.com/news-release/2024/07/01/2906369/0/en/Idorsia-s-JERAYGO-aprocitentan-approved-in-Europe-as-first-and-only-ERA-for-the-treatment-of-resistant-hypertension.html
https://www.globenewswire.com/news-release/2024/06/28/2906054/0/en/Higher-cantonal-composition-authority-issues-written-court-decision-in-respect-to-the-amendments-to-the-terms-of-the-2024-convertible-bonds.html
https://www.globenewswire.com/news-release/2024/06/25/2904032/0/en/Higher-cantonal-composition-authority-approved-the-amendments-to-the-terms-of-the-2024-convertible-bonds.html
https://www.globenewswire.com/news-release/2024/06/13/2898055/0/en/Idorsia-holds-its-Annual-General-Meeting-of-Shareholders.html
https://www.globenewswire.com/news-release/2024/06/03/2891892/0/en/New-data-with-daridorexant-to-be-presented-at-SLEEP-2024.html
https://www.globenewswire.com/news-release/2024/05/31/2891256/0/en/Data-from-the-PRECISION-study-of-aprocitentan-to-be-presented-at-the-European-Society-of-Hypertension-Annual-Meeting-2024.html
https://endpts.com/idorsias-jean-paul-clozel-retires-as-ceo-plots-next-steps-crispr-therapeutics-nabs-cmo-from-sanofi/
Market Place
Share 
